Targeting gut microbiota and immune crosstalk: potential mechanisms of natural products in the treatment of atherosclerosis
Atherosclerosis (AS) is a chronic inflammatory reaction that primarily affects large and medium-sized arteries. It is a major cause of cardiovascular disease and peripheral arterial occlusive disease. The pathogenesis of AS involves specific structural and functional alterations in various populatio...
Main Authors: | Jinpeng Jing, Jing Guo, Rui Dai, Chaojun Zhu, Zhaohui Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1252907/full |
Similar Items
-
Natural products against inflammation and atherosclerosis: Targeting on gut microbiota
by: Bing Deng, et al.
Published: (2022-12-01) -
Gut Microbiota in Hypertension and Atherosclerosis: A Review
by: Barbara J. H. Verhaar, et al.
Published: (2020-09-01) -
Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis
by: Chih-Fan Yeh, et al.
Published: (2020-11-01) -
Characterization of gut microbiota in adults with coronary atherosclerosis
by: Yu Dong, et al.
Published: (2023-05-01) -
Probiotics Regulate Gut Microbiota: An Effective Method to Improve Immunity
by: Xinzhou Wang, et al.
Published: (2021-10-01)